Daniel E Felsing

Title: The Innovations of Daniel E. Felsing

Introduction

Daniel E. Felsing is an accomplished inventor based in Galveston, Texas. He has made significant contributions to the field of pharmacology, particularly through his work on G-protein-coupled receptor agonists. With a total of two patents to his name, Felsing's innovations are paving the way for new therapeutic options.

Latest Patents

Felsing's latest patents focus on Heterocyclic G-protein-coupled receptor 52 (GPR52) agonists. These embodiments are directed to novel GPR52 activators, specifically a series of novel 1-(pyrimidin-4-yl)indoline-4-carboxamide analogs. These compounds have been identified as potent and selective GPR52 agonists. The optimized GPR52 agonist can serve as a valuable pharmacological tool or a drug candidate for investigating the physiological and therapeutic potential of GPR52 activation for various human diseases.

Career Highlights

Throughout his career, Felsing has worked with notable institutions, including the University of Texas System and the Board of Regents of the University of Texas System. His work has contributed to advancements in understanding GPR52 and its implications in human health.

Collaborations

Felsing has collaborated with esteemed colleagues such as Jia Zhou and John A. Allen. These partnerships have enhanced the research and development of his innovative ideas.

Conclusion

Daniel E. Felsing's contributions to the field of pharmacology through his patents on GPR52 agonists highlight his role as a significant inventor. His work continues to influence the development of new therapeutic strategies for various diseases.